Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LENITA HANSON

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1225128572
CMS profile
146171
Location
PORT CHARLOTTE, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$5,272.28

98 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LENITA HANSON

NPI 1225128572 · CMS profile ID 146171

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

PORT CHARLOTTE, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1225128572?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LENITA HANSON, NPI 1225128572, CMS profile ID 146171. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1225128572?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). LENITA HANSON, NPI 1225128572, CMS profile ID 146171. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1225128572?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
LENITA HANSON, NPI 1225128572, CMS profile ID 146171, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1225128572?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

98 matching records · $5,272.28 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 98 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–98 of 98.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
SANOFI-AVENTIS U.S. LLC $19.5307/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744156187 CMS
Xeris Pharmaceuticals, Inc. $19.7107/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739715031 CMS
Merck Sharp & Dohme Corporation $23.8907/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747650405 CMS
AbbVie Inc. $19.9207/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721855577 CMS
Insulet Corporation $400.0007/08/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748425665 CMS
SANOFI-AVENTIS U.S. LLC $22.6707/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744156185 CMS
Insulet Corporation $1,600.0007/01/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748425655 CMS
SANOFI-AVENTIS U.S. LLC $24.6407/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744156181 CMS
IBSA Pharma Inc. $13.7806/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719682955 CMS
AstraZeneca Pharmaceuticals LP $13.4506/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735752285 CMS
SANOFI-AVENTIS U.S. LLC $15.5506/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744156179 CMS
Lilly USA, LLC $15.7706/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728538791 CMS
Insulet Corporation $4.7306/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748419065 CMS
Lilly USA, LLC $23.9006/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728525027 CMS
Insulet Corporation $23.0106/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748419063 CMS
Insulet Corporation $10.0006/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748419069 CMS
Lilly USA, LLC $18.0906/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728542105 CMS
SANOFI-AVENTIS U.S. LLC $14.5406/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744156175 CMS
Amarin Pharma Inc. $27.7606/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740073921 CMS
Janssen Pharmaceuticals, Inc $23.3506/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719264077 CMS
Novo Nordisk Inc $21.7905/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744889669 CMS
SANOFI-AVENTIS U.S. LLC $14.2105/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744156167 CMS
AstraZeneca Pharmaceuticals LP $21.4705/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736140105 CMS
Dexcom, Inc. $16.2405/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 752067099 CMS
SANOFI-AVENTIS U.S. LLC $17.1905/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744156165 CMS
IBSA Pharma Inc. $15.7705/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719680163 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $12.7704/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720945633 CMS
SANOFI-AVENTIS U.S. LLC $26.0604/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744156157 CMS
SANOFI-AVENTIS U.S. LLC $8.5004/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744156183 CMS
Insulet Corporation $400.0004/15/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748425663 CMS
Insulet Corporation $19.9704/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748419055 CMS
Insulet Corporation $13.7504/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748419059 CMS
Novo Nordisk Inc $15.9704/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744686405 CMS
Xeris Pharmaceuticals, Inc. $15.3504/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739715029 CMS
IBSA Pharma Inc. $12.3904/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719680043 CMS
AstraZeneca Pharmaceuticals LP $21.4703/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736419845 CMS
Insulet Corporation $800.0003/18/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748425659 CMS
Novo Nordisk Inc $21.5903/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744686397 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.5703/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720945639 CMS
SANOFI-AVENTIS U.S. LLC $12.0002/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744156149 CMS
Companion Medical, Inc. $14.8102/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 714619199 CMS
Dexcom, Inc. $12.0602/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 752067097 CMS
SANOFI-AVENTIS U.S. LLC $9.9502/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744156139 CMS
Lilly USA, LLC $13.4801/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728535229 CMS
Companion Medical, Inc. $22.0601/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 714618887 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.5701/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737538203 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.2101/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747189837 CMS
Dexcom, Inc. $11.7401/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 752067095 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,975.59 87
PY2020 $5,272.28 98
PY2021 $2,329.08 109
PY2022 $2,210.35 71
PY2023 $2,678.25 40
PY2024 $32,950.51 70
PY2025 $26,416.29 30

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $2,499.12 2
PY2025 Principal investigator $35,993.00 10
PY2024 Recipient $2,232.60 2
PY2024 Principal investigator $155,852.73 28
PY2023 Recipient $31,839.85 8
PY2023 Principal investigator $217,611.56 47
PY2022 Recipient $26,323.16 16
PY2022 Principal investigator $178,832.40 104
PY2021 Principal investigator $232,629.35 435
PY2020 Principal investigator $169,198.07 63
PY2019 Principal investigator $175,595.57 83

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $400.00 09/09/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3 study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney disease a No dispute reported 06/30/2026 1225414610
Recipient Bayer Healthcare Pharmaceuticals Inc. $416.52 08/05/2025 Covered Recipient Physician BAY 948862, Clinical characteristics, treatment patterns and outcomes of patients treated with Finerenone in routine clinical practice A prospective non-interventional study. No dispute reported 06/30/2026 1225400908
Recipient Bayer Healthcare Pharmaceuticals Inc. $2,082.60 06/19/2025 Covered Recipient Physician BAY 948862, Clinical characteristics, treatment patterns and outcomes of patients treated with Finerenone in routine clinical practice A prospective non-interventional study. No dispute reported 06/30/2026 1225400910
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $373.00 06/13/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3 study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney disease a No dispute reported 06/30/2026 1225412299
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $3,696.00 05/29/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3 study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney disease a No dispute reported 06/30/2026 1225412830
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $5,400.00 05/19/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3 study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney disease a No dispute reported 06/30/2026 1225412764
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,621.00 04/28/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
BAY 948862, A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney No dispute reported 06/30/2026 1225406150
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $7,459.00 03/27/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
BAY 948862, A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney No dispute reported 06/30/2026 1225402915
Principal investigator 1 Siemens Medical Solutions USA, Inc. $2,850.00 03/25/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
Specimen Collection for Siemens Thyroid Antibody Assays No dispute reported 06/30/2026 1173556700
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $8,323.00 02/20/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
BAY 948862, A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney No dispute reported 06/30/2026 1225405938
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,621.00 01/28/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
BAY 948862, A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney No dispute reported 06/30/2026 1225404606
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $4,250.00 01/09/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
BAY 948862, A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney No dispute reported 06/30/2026 1225403893